Vantictumab

DB12956InvestigationalProtein Based Therapies

Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.

Mechanism
Curator reviewed
Also known as
OMP-18R5

Resolves to

Compound
UNII88WBI2D80SCAS1345009-45-1
Targets
O75084FZD7Q13467FZD5Q14332FZD2Q9H461FZD8Q9UP38FZD1

What you can answer from here — as of June 15, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Vantictumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In